Protecting public health in the age of bioterrorism surveillance: Is the price right?

Journal of Environmental Health

Volumn 68, Issue 5, 2005, Pages 9-13

  Schneider, Helen ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH MONITORING; PUBLIC HEALTH; TERRORISM;

AEROSOL; AIR SAMPLING; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; EPIDEMIC; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INFECTION RISK; LABORATORY TEST; PROBABILITY; PUBLIC HEALTH SERVICE; STATISTICAL MODEL; TERRORISM; WORLD HEALTH ORGANIZATION;

ANTHRAX; BACILLUS ANTHRACIS; BIOTERRORISM; COST-BENEFIT ANALYSIS; DISASTER PLANNING; ENVIRONMENTAL MONITORING; HUMANS; PUBLIC HEALTH;

BACILLUS ANTHRACIS;

EID: 28344437505     PISSN: 00220892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Berg, R. (2004). Terrorism response and the environmental health role: The million-dollar (and some) question. Journal of Environmental Health, 67(2), 29-39.
2. Fabian, N. (2002). Post September 11: Some reflections on the role of environmental health in terrorism response. Journal of Environmental Health, 64(9), 78, 77, 65.
3. Frist, B. (2002). Public health and national security: The critical role of increased federal support. Health Affairs, 21(6), 117-130.
4. Haddix, A.C., Teutsch, S.M., Shaffer, P.A., & Dunet, D.O. (1996). Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press.
5. Henretig, F (2002). Biological and chemical terrorism defense: A view from the "front lines" of public health. American Journal of Public Health, 91 (5), 718-721.
6. Inglesby, T.V. (1999). Anthrax: A possible case history. Emerging infectious Diseases, 5(4), 556-560.
7. Inglesby, T.V, Henderson, O.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Friedlander, A.M., Hauer, J., McDade, J., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., & Tonat, K. (1999). Anthrax as a biological weapon: Medical and public health management: Working group on civilian biodefense. Journal of the American Medical Association, 281(18), 1735-1745.
8. Jernigan, J.A., Stephens, D.S., Ashford, D.A., Omenaca, C., Topiel, M.S., Galbraith, M., Tapper, M., Fisk, T.L., Zaki, S., Popovic, T., Meyer, R.F., Quinn, C.P., Harper, S.A., Fridkin, S.K., Sejvar, JJ., Shepard, C.W., McConnell, M., Guarner, J., Shieh, W.J., Malecki, J.M., Gerberding, J.L., Hughes, J.M., & Perkins, B.A., Anthrax Bioterrorism Investigation Team. (2001). Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerging Infectious Diseases, 7(6), 933-944.
9. Kaufmann, A.F., Meltzer, M.I., & Schmid, G.P (1997). The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? Emerging Infectious Diseases, 3(2), 83-94.
10. Lipscomb, J., Weinstein, M.C., & Torrance, G.W. (1966). Time preference. In M.R. Gold, J.E. Siegel, L.B. Russell, & M.C. Weistein (Eds.), Cost-effectiveness in health and medicine (pp. 214-235). New York: Oxford University Press.
11. Office of Technology Assessment, U.S. Congress. (1993). Proliferation of weapons of mass destruction (OTA Publication No. ISC-559). Washington, DC: U.S. Government Printing Office.
12. Schuler, A. (2004). Billions for biodefense: Federal agency biodefense funding, FY2001-FY2005. Biosecurity and Bioterronsm, 2(2), 86-96.
13. Stein, B.D., Tanielian T.L., Eisenman, D.P., Keyser, D.J., Burnam, M.A., & Pincus, H.A. (2004). Emotional and behavioral consequences of bioterrorism: Planning a public health response. Mubank Quarterly, 82(3), 413-55.
14. StJohn, R., Finlay, B, & Blair, C. (2001). Bioterrorism in Canada: An economic assessment of prevention and postattack response. Canadian Journal of Infectious Diseases, 12(5), 275-284.
15. U.S. Environmental Protection Agency. (1997). The benefits and costs of the Clean Air Act: 1970-1990 (EPA 410-R-97-002). http://www.epa.gov/air/sect812/ copy.html (25 Aug. 2005).
16. Wein, L.M., Craft, D.L., & Kaplan, E.H. (2003). Emergency response to an anthrax attack. Proceeding of the National Academy of Sciences, 100(7), 4346-4351.
17. Wenner, K.A. & Kenner, J.R. (2004). Anthrax. Dermatologic Clinics, 22(3), 247-256.
18. World Health Organization. (1970). Health aspects of biological weapons: Report of a WHO group of experts. Geneva, Switzerland: Author.